Cargando…
Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO). METHODS: Thirty-six eyes of 18 patients with GO and 36...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835242/ https://www.ncbi.nlm.nih.gov/pubmed/29670918 http://dx.doi.org/10.1155/2018/1454616 |
_version_ | 1783303778143830016 |
---|---|
author | Bruscolini, Alice La Cava, Maurizio Gharbiya, Magda Sacchetti, Marta Restivo, Lucia Nardella, Chiara Marenco, Marco Lambiase, Alessandro |
author_facet | Bruscolini, Alice La Cava, Maurizio Gharbiya, Magda Sacchetti, Marta Restivo, Lucia Nardella, Chiara Marenco, Marco Lambiase, Alessandro |
author_sort | Bruscolini, Alice |
collection | PubMed |
description | PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO). METHODS: Thirty-six eyes of 18 patients with GO and 36 eyes of 18 age-matched control subjects were included in this retrospective observational study. All the subjects underwent a complete ophthalmological evaluation, including clinical activity score (CAS) and exophthalmometry. The SDOCT images of the choroid were obtained by EDI modality. RESULTS: Choroidal thickness was significantly increased in GO than in control eyes (p < 0.01). A significant correlation was found between choroidal thickness and CAS, proptosis, and the duration of disease (p < 0.05). CONCLUSION: This study shows that choroidal thickness, evaluated with EDI-OCT, is significantly increased in patients with GO and correlates with the activity of the disease, proptosis, and duration of the disease. The choroidal thickening may reflect the ocular hemodynamic changes, and enhanced depth imaging optical coherence tomography may be a useful tool for the evaluation of orbital congestion and management of patients with Graves' disease and orbital involvement. |
format | Online Article Text |
id | pubmed-5835242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-58352422018-04-18 Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography Bruscolini, Alice La Cava, Maurizio Gharbiya, Magda Sacchetti, Marta Restivo, Lucia Nardella, Chiara Marenco, Marco Lambiase, Alessandro J Immunol Res Research Article PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO). METHODS: Thirty-six eyes of 18 patients with GO and 36 eyes of 18 age-matched control subjects were included in this retrospective observational study. All the subjects underwent a complete ophthalmological evaluation, including clinical activity score (CAS) and exophthalmometry. The SDOCT images of the choroid were obtained by EDI modality. RESULTS: Choroidal thickness was significantly increased in GO than in control eyes (p < 0.01). A significant correlation was found between choroidal thickness and CAS, proptosis, and the duration of disease (p < 0.05). CONCLUSION: This study shows that choroidal thickness, evaluated with EDI-OCT, is significantly increased in patients with GO and correlates with the activity of the disease, proptosis, and duration of the disease. The choroidal thickening may reflect the ocular hemodynamic changes, and enhanced depth imaging optical coherence tomography may be a useful tool for the evaluation of orbital congestion and management of patients with Graves' disease and orbital involvement. Hindawi 2018-02-18 /pmc/articles/PMC5835242/ /pubmed/29670918 http://dx.doi.org/10.1155/2018/1454616 Text en Copyright © 2018 Alice Bruscolini et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bruscolini, Alice La Cava, Maurizio Gharbiya, Magda Sacchetti, Marta Restivo, Lucia Nardella, Chiara Marenco, Marco Lambiase, Alessandro Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography |
title | Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography |
title_full | Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography |
title_fullStr | Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography |
title_full_unstemmed | Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography |
title_short | Management of Patients with Graves' Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography |
title_sort | management of patients with graves' disease and orbital involvement: role of spectral domain optical coherence tomography |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835242/ https://www.ncbi.nlm.nih.gov/pubmed/29670918 http://dx.doi.org/10.1155/2018/1454616 |
work_keys_str_mv | AT bruscolinialice managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT lacavamaurizio managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT gharbiyamagda managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT sacchettimarta managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT restivolucia managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT nardellachiara managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT marencomarco managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography AT lambiasealessandro managementofpatientswithgravesdiseaseandorbitalinvolvementroleofspectraldomainopticalcoherencetomography |